Recent News Releases
For investor-related news, see our ASX releases here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 24, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
Mar 22, 2017The New England Journal of Medicine published data from the COMPACT study which demonstrated the safety and efficacy of CSL830 to prevent HAE attacks.
22 Mar 2017 KING OF PRUSSIA, Pa — 22 March 2017 Median reduction in hereditary angioedema (HAE) attack rate relative to placebo was 95% at the highest dose studied Data show up to 40% of HAE...
-
Mar 21, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
Mar 14, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
Mar 14, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
Mar 14, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
Mar 1, 2017PATH study evaluated subcutaneous immunoglobulin efficacy and safety for treating Chronic Inflammatory Demyelinating Polyneuropathy
01 Mar 2017 KING OF PRUSSIA, Pa — 01 March 2017 Global biotherapeutics leader CSL Behring announced today that it has completed the largest ever Chronic Inflammatory Demyelinating Polyneuropathy...
-
Feb 25, 2017
Today the world’s no. 2 influenza vaccine provider, Seqirus, announced a £22.1m investment for its UK manufacturing site in Liverpool. 25 Feb 2017 The company, which is part of global...
-
Feb 22, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
-
Feb 20, 2017
PDF VERSION OF PRESS RELEASE Back to overview of Press Releases